[SSRI / SSNRI: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018013531
German
Original Title:
SSRI /SSNRI: Evidenzbericht zur S3-Leitlinie Definition, Ursachen, Diagnostik und Therapie des Fibromyalgiesyndroms
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/v24-12.html
Year Published:
2025
URL for published report:
https://www.iqwig.de/download/v24-12a_selektive-serotonin-und-serotonin-noradrenalin-wiederaufnahmehemmer_evidenzbericht_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
DOI:
10.60584/V24-12A
MeSH Terms
- Fibromyalgia
- Antidepressive Agents
- Selective Serotonin Reuptake Inhibitors
- Serotonin and Noradrenaline Reuptake Inhibitors
- Disease Management
- Practice Guideline
Keywords
- Selective Serotonin Reuptake Inhibitors
- Serotonin and Noradrenaline Reuptake Inhibitors
- Fibromyalgia
- Systematic Review
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.